Noncoding RNA, which accounts for most of the human transcriptome, has increasingly intrigued scientists as a diagnostic and prognostic tool for cancer. These RNA molecules often exit cells, travel through the bloodstream, and carry key information about cancer’s presence and development, making them promising blood-based biomarkers. In this webinar, Daniel Kim will discuss how he uncovered cancer-specific RNA profiles in patients’ blood, enabling him to develop RNA liquid biopsy technology for early cancer detection.
Topics to be covered
- Identifying enriched repetitive noncoding RNA sequences in the blood of patients with cancer
- Harnessing noncoding RNA to create a non-invasive liquid biopsy to detect early-stage cancer
Tuesday, December 10th, 2024 | 1:00 PM - 2:00 PM Eastern Time
This webinar will be available to view live and on demand.
Speaker
Daniel Kim, PhD
Assistant Professor
University of California, Santa Cruz
